Edwige Nicodème
Galderma (Switzerland)(CH)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Histone Deacetylase Inhibitors Research, Multiple Myeloma Research and Treatments, Psoriasis: Treatment and Pathogenesis, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Suppression of inflammation by a synthetic histone mimic(2010)1,563 cited
- → Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans(2017)355 cited
- → Discovery and Characterization of Small Molecule Inhibitors of the BET Family Bromodomains(2011)334 cited
- → Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains(2013)302 cited
- → The Discovery of I-BET726 (GSK1324726A), a Potent Tetrahydroquinoline ApoA1 Up-Regulator and Selective BET Bromodomain Inhibitor(2014)187 cited
- → From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151(2012)118 cited
- → Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia(2015)104 cited
- → Identification of Liver Receptor Homolog-1 as a Novel Regulator of Apolipoprotein AI Gene Transcription(2004)92 cited
- → Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin(2016)82 cited
- → Discovery and Optimization of Potent, Selective, and in Vivo Efficacious 2-Aryl Benzimidazole BCATm Inhibitors(2016)44 cited